Viewing Study NCT00816400


Ignite Creation Date: 2025-12-26 @ 12:18 PM
Ignite Modification Date: 2026-01-13 @ 9:18 AM
Study NCT ID: NCT00816400
Status: COMPLETED
Last Update Posted: 2018-06-26
First Post: 2008-12-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors.
Sponsor: MedImmune LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: MI-CP187
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators